l General Information |
Product Name | TAPI-1 |
General description | TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors. |
Synonym | N-[(2S)-1-[[(2S)-1-(2-aminoethylamino)-1-oxopropan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N'-hydroxy-2-(2-methylpropyl)butanediamide |
Purity | ≥98.0%(HPLC) | CAS Number | 171235-71-5 |
Formula | C26H37N5O5 | Molecular Weight | 499.60 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | ≥50mg/mL |
Water | ≥50mg/mL(warmed) |
l Biological Information |
Biochem/Physiol
Actions | TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors. |
l Storage |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
